Intra-Cellular Ther
(ITCI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 308,698 | 149,517 | 150,365 | 93,765 | 61,446 |
| Marketable Securities | 694,118 | 350,174 | 443,290 | 319,968 | 597,402 |
| Receivables | 166,500 | 114,018 | 75,189 | 20,156 | 10,765 |
| Inventories | 26,283 | 11,647 | 23,920 | 7,948 | 7,056 |
| TOTAL | $1,307,364 | $667,799 | $737,957 | $467,281 | $690,905 |
| Non-Current Assets | |||||
| PPE Net | 1,468 | 1,654 | 1,913 | 1,791 | 1,998 |
| Other Non-Current Assets | 58,080 | 58,842 | 14,910 | 20,850 | 24,411 |
| TOTAL | $59,548 | $60,496 | $16,823 | $22,641 | $26,409 |
| Total Assets | $1,366,912 | $728,295 | $754,780 | $489,922 | $717,314 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 26,074 | 11,452 | 10,395 | 8,691 | 5,502 |
| Accrued Expenses | 99,989 | 55,308 | 42,653 | 31,970 | 22,804 |
| TOTAL | $205,704 | $123,545 | $83,236 | $53,357 | $36,853 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 12,748 | 13,326 | 15,474 | 18,675 | 23,600 |
| TOTAL | $12,748 | $13,326 | $15,474 | $18,675 | $23,600 |
| Total Liabilities | $218,452 | $136,871 | $98,710 | $72,032 | $60,454 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 106,328 | 96,807 | 95,280 | 93,594 | 80,917 |
| Common Shares | 11 | 10 | 9 | 8 | 8 |
| Retained earnings | -1,691,836 | -1,617,160 | -1,477,486 | -1,221,230 | -937,104 |
| Other shareholders' equity | 191 | 104 | -4,190 | -364 | 481 |
| TOTAL | $1,148,460 | $591,424 | $656,070 | $417,890 | $656,860 |
| Total Liabilities And Equity | $1,366,912 | $728,295 | $754,780 | $489,922 | $717,314 |